EGFR and head and neck squamous cell carcinoma: In vitro, we found that CAL27 miR-223 cells were less sensitive than CAL27 cells to conventional chemotherapeutic agents commonly used in HNSCC (namely cisplatin, 5-fluorouracil and docetaxel), as well as to the anti-EGFR monoclonal antibody cetuximab.